Clinical Trials Arena December 12, 2025
At CDMI Europe 2025, experts agreed that AI is the key technology to improve efficiencies in clinical trial data management.
For years, one of the biggest barriers to effectively implementing artificial intelligence (AI) into clinical trial data management has been a lack of trust in its capabilities. Although this concern is gradually fading, challenges remain – particularly those related to patient safety and maintaining data accuracy.
At Arena International’s Clinical Data Management Innovation (CDMI) Europe 2025 conference in Barcelona, held on 3-4 December, participants identified validation, regulation and risk management as key areas that must be strengthened to enable effective integration of AI into workflows.
Validation remains key barrier
While AI is already being integrated into the daily workflow of...







